Seeking Alpha

Jason Napodano, CFA  

View Jason Napodano, CFA's StockTalks BY TICKER:

  • Jason Napodano, CFA
    $CRBP shares up 100% on getting Fast Track designation from the FDA for systemic sclerosis.
    Aug 19, 10:35 AM
    Reply (1)
    • Clayton Rulli: See all those insider buys yesterday? Such BS I'm sure they had no clue about the fast track announcement today. HA!
      Aug 19, 12:50 PM
      • Jason Napodano, CFA
        Why I think $CANF is undervalued based on P2/3 CF101 in psoriasis alone >> http://bit.ly/1ge6qb5
        Aug 6, 11:36 AM
        Reply
          • Jason Napodano, CFA
            Auspex Hits Home Run With Phase 3 Data In Huntington's Chorea $ASPX http://seekingalpha.com/a/1n8sz
            12/17/14
            Reply
              • Jason Napodano, CFA
                Auspex Hits Homerun With Phase 3 Data In Huntington's Chorea $ASPX http://seekingalpha.com/p/24e1t
                12/17/14
                Reply (1)
                • jacobite47: Thank you Jason.
                  12/17/14
                  • Jason Napodano, CFA
                    Cynapsus Shares Set For Major Move Higher On Backs Of Positive Phase 2 Data $CYNAF http://seekingalpha.com/p/22lpf
                    11/19/14
                    Reply (3)
                  • View all 3 replies
                    • TimeOnTarget: I'll go better than brichnyc: Great Job. You were on Cynapsus before anyone else I saw, you were on it hard, and you have just nailed it.
                      11/19/14
                    • freedom_has_few_friends: Yes, thank you Jason for pointing me to this investment. Looking more and more like they have a promising treatment here.
                      11/19/14
                      • Jason Napodano, CFA
                        Buy Auspex Ahead Of Pivotal Phase 3 Data In December 2014 $ASPX http://seekingalpha.com/a/1lb4n
                        11/13/14
                        Reply
                          • Jason Napodano, CFA
                            Article (and report link inside) on a new player in the Fish Oil / Omega-3 market >> http://bit.ly/1p6lU4B $MTNB $AMRN $GSK $AZN
                            10/30/14
                            Reply
                              • Jason Napodano, CFA
                                Neurotrope Tackles Alzheimer's Disease With Novel Mechanism $NTRP http://seekingalpha.com/a/1j7g7
                                10/21/14
                                Reply
                                  • Jason Napodano, CFA
                                    InVivo, Neuralstem Treat Spinal Cord Injury Patients $CUR http://seekingalpha.com/a/1iyk7
                                    10/16/14
                                    Reply (1)
                                    • matratra: CUR- In vitro would be welcome.
                                      10/16/14